WallStreetZenWallStreetZen

NASDAQ: AIRS
AIRSCULPT TECHNOLOGIES INC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AIRS

Based on 4 analysts offering 12 month price targets for AIRSCULPT TECHNOLOGIES INC.
Min Forecast
$17.00+112.23%
Avg Forecast
$21.00+162.17%
Max Forecast
$27.00+237.08%

Should I buy or sell AIRS stock?

Based on 4 analysts offering ratings for AIRSCULPT TECHNOLOGIES INC.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AIRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
SVB Leerink
Bottom 16%
16
BuyMaintains$27.00+237.08%2022-03-14
Raymond James
Top 28%
73
BuyInitiates Coverage On$18.00+124.72%2021-11-23
Morgan Stanley
Bottom 1%
1
Strong BuyInitiates Coverage On$17.00+112.23%2021-11-23
Piper Sandler
Top 10%
91
Strong BuyInitiates Coverage On$22.00+174.66%2021-11-23

1 of 1

Forecast return on equity

Is AIRS forecast to generate an efficient return?
Company
68.1%
Industry
-123.97%
Market
32.71%
AIRS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AIRS forecast to generate an efficient return on assets?
Company
29.53%
Industry
8.37%
AIRS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AIRS earnings per share forecast

What is AIRS's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.05
Avg 2 year Forecast
$0.49
Avg 3 year Forecast
$0.77

AIRS revenue forecast

What is AIRS's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$176.7M
Avg 2 year Forecast
$222.0M
Avg 3 year Forecast
$258.3M

AIRS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
AIRS$8.01$21.00+162.17%Strong Buy
PNTG$17.44$25.25+44.78%Buy
ATIP$1.84$4.00+117.39%Hold
CMPS$8.35$74.00+786.23%Strong Buy
AVAH$2.93$11.07+277.85%Strong Buy
View Top Medical Care Facility Stocks

AIRSCULPT TECHNOLOGIES Stock Forecast FAQ

Is AIRSCULPT TECHNOLOGIES Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: AIRS) stock is to Strong Buy AIRS stock.

Out of 4 analysts, 2 (50%) are recommending AIRS as a Strong Buy, 2 (50%) are recommending AIRS as a Buy, 0 (0%) are recommending AIRS as a Hold, 0 (0%) are recommending AIRS as a Sell, and 0 (0%) are recommending AIRS as a Strong Sell.

What is AIRS's earnings growth forecast for 2022-2024?

(NASDAQ: AIRS) AIRSCULPT TECHNOLOGIES's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 5.03%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.78%.

AIRSCULPT TECHNOLOGIES's earnings in 2022 is N/A.On average, 3 Wall Street analysts forecast AIRS's earnings for 2022 to be $2,782,008, with the lowest AIRS earnings forecast at $1,669,205, and the highest AIRS earnings forecast at $3,894,811. On average, 3 Wall Street analysts forecast AIRS's earnings for 2023 to be $27,263,675, with the lowest AIRS earnings forecast at $7,789,622, and the highest AIRS earnings forecast at $49,519,737.

In 2024, AIRS is forecast to generate $42,842,919 in earnings, with the lowest earnings forecast at $21,699,660 and the highest earnings forecast at $63,986,177.

What is AIRS's revenue growth forecast for 2022-2024?

(NASDAQ: AIRS) AIRSCULPT TECHNOLOGIES's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.29%.

AIRSCULPT TECHNOLOGIES's revenue in 2022 is N/A.On average, 4 Wall Street analysts forecast AIRS's revenue for 2022 to be $9,830,502,409, with the lowest AIRS revenue forecast at $9,722,560,510, and the highest AIRS revenue forecast at $9,881,691,350. On average, 4 Wall Street analysts forecast AIRS's revenue for 2023 to be $12,352,336,749, with the lowest AIRS revenue forecast at $12,258,082,328, and the highest AIRS revenue forecast at $12,496,778,588.

In 2024, AIRS is forecast to generate $14,372,853,301 in revenue, with the lowest revenue forecast at $14,200,480,104 and the highest revenue forecast at $14,566,592,317.

What is AIRS's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: AIRS) forecast ROA is 29.53%, which is higher than the forecast US Medical Care Facilities industry average of 8.37%.

What is AIRS's Price Target?

According to 4 Wall Street analysts that have issued a 1 year AIRS price target, the average AIRS price target is $21.00, with the highest AIRS stock price forecast at $27.00 and the lowest AIRS stock price forecast at $17.00.

On average, Wall Street analysts predict that AIRSCULPT TECHNOLOGIES's share price could reach $21.00 by Mar 14, 2023. The average AIRSCULPT TECHNOLOGIES stock price prediction forecasts a potential upside of 162.17% from the current AIRS share price of $8.01.

What is AIRS's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: AIRS) AIRSCULPT TECHNOLOGIES's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that AIRS's EPS will be $0.05 for 2022, with the lowest EPS forecast at $0.03, and the highest EPS forecast at $0.07. On average, analysts forecast that AIRS's EPS will be $0.49 for 2023, with the lowest EPS forecast at $0.14, and the highest EPS forecast at $0.89. In 2024, AIRS's EPS is forecast to hit $0.77 (min: $0.39, max: $1.15).

What is AIRS's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: AIRS) forecast ROE is 68.1%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.